ARTICLE | Company News
Indivumed, Johns Hopkins University deal
November 23, 2009 8:00 AM UTC
Indivumed's Inostics GmbH subsidiary received an exclusive, worldwide license to the university's technology to detect phosphoinositide 3-kinase (PI3K) catalytic subunit alpha polypeptide mutations i...